Atherectomy and Thrombectomy Devices Market Segmented By Rheolytic, Aspiration, Rotational, Ultrasound Device Type in Hospitals, Clinics
Industry: Healthcare
Published Date: May-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 306
Report ID: PMRREP33105
The atherectomy and thrombectomy devices market is anticipated to have a significant CAGR of 5.7% during the period of 2022-2032.
The atherectomy and thrombectomy devices market is predicted to grow from US$ 3.5 billion in 2022 to US$ 6 billion in 2032. Previously, the market was thriving at a higher CAGR of 6.3% (2015-2021), resulting in a market size of US$ 3.3 billion in 2021.
“Advantageous reimbursement landscape for atherectomy procedures, increased research activity in the field of atherectomy, and faster expansion of the atherectomy and thrombectomy devices market.”
Due to the increased healthcare costs and the prevalence of cardiovascular disorders, demand for atherectomy and thrombectomy devices is considerable. The development of wearable atherectomy and thrombectomy devices, as well as developments in product development, are projected to contribute to the expansion of the global atherectomy and thrombectomy devices market.
| Attributes | Details |
|---|---|
|
Atherectomy and Thrombectomy Devices Market CAGR (2022-2032) |
5.7% |
|
Atherectomy and Thrombectomy Devices Market Market Size (2022) |
US$ 3.5 billion |
|
Atherectomy and Thrombectomy Devices Market Size (2032) |
US$ 6 billion |
The COVID-19 pandemic has had an impact on the market for atherectomy and thrombectomy devices. Several cardiovascular operations, as well as non-essential therapies, have been postponed. Moreover, numerous corporations postponed non-COVID-19-related research, resulting in delayed product introductions.
In early 2020, certain difficulties in acquiring raw materials from afflicted nations, such as China, were detected, but these disruptions are unlikely to have a large influence in the future. However, as previous prohibitions in numerous nations have eased, atherectomy and thrombectomy devices market expansion may restart.
Several elective procedures and outpatient visits were suspended during the COVID outbreak, which reduced demand for these devices in the atherectomy and thrombectomy devices market, as healthcare system guidelines around the world temporarily focused all of their efforts on managing the COVID-19 infection patient load during the initial lockdown period.
Activities in a variety of industries, including healthcare services, have begun to return to pre-COVID levels, presenting substantial opportunities for atherectomy and thrombectomy devices to expand at a large revenue level during the forecast period.
The growing inclination for minimally invasive surgeries is driving the atherectomy and thrombectomy devices market devices. In contrast to traditional open surgery, doctors use a range of techniques to operate with minimal damage to the body in minimally invasive surgery.
Minimally invasive surgery is linked to less discomfort, a shorter hospital stay, and fewer difficulties in general. Atherectomy is a minimally invasive procedure for artery treatment. Owing to the various features, such as reduced pain, less scarring, less tissue harm, a shorter hospital stay, and a greater accuracy rate, this operation is in high demand.
Other causes include ongoing product research and commercialization, attractive medical reimbursement scenarios in mature markets, and the strengthening of large retailers' distribution systems. All this leads to encouraging the atherectomy and thrombectomy devices market share.
The scarcity of healthcare workers is particularly acute in rural areas, since the majority of healthcare facilities are held by the government. Government programs are investing considerably in improving the health of rural residents, which in return improves the atherectomy and thrombectomy devices market statistics.
However, due to a dearth of trained people with the expertise to handle such devices, the minimally invasive devices category is unable to take advantage of this opportunity. This, combined with other factors such as rigorous regulations, is projected to impede the market's growth.
| Attributes | Atherectomy and Thrombectomy Devices Market |
|---|---|
|
CAGR (2022-2032) |
5.7% |
|
Market Value (2026) |
US$ 4.37 billion |
|
Growth Factor |
A growing inclination for minimally invasive surgeries is driving the market growth. |
|
Opportunity |
Features, such as reduced pain, less scarring, less tissue harm, and shorter hospital stays, expand the market's prospects. |
|
Key Trends |
Government programs are investing considerably in improving the health of rural residents and creating a higher scope for the market. |
| Attributes | Bariatric Surgery Devices Market |
|---|---|
|
CAGR (2022-2032) |
4.5% |
|
Market Value (2026) |
US$ 2.49 billion |
|
Growth Factor |
Demand is high due to the growing prevalence of morbid obesity around the world. |
|
Opportunity |
Established and new medical surgeons are honing and qualifying their surgical abilities to expand the market's prospects. |
|
Key Trends |
The prevalence of major health concerns, like excessive cholesterol, hypertension, creates a higher scope for the market. |
| Attributes | Surgical Stapling Devices Market |
|---|---|
|
CAGR (2022-2032) |
8.4% |
|
Market Value (2026) |
US$ 4.19 billion |
|
Growth Factor |
The use of surgical stapling devices in bariatric procedures is increasing, which is driving up demand. |
|
Opportunity |
The rise in laparoscopic procedures elected by the patients offers attractive business opportunities. |
|
Key Trends |
Manufacturers of surgical stapling devices are continuously investing in research and development and have higher scope in the market. |
The atherectomy and thrombectomy device market share is recovering thanks to the approval and administration of several COVID-19 vaccines around the world. The post-Covid market was worth US$ 2.26 billion in 2015, and it is worth US$ 3.5 billion in 2022, although growth is still moderate. However, few organizations are prepared to handle this infusion of capital with the speed and efficiency that it requires.
The global atherectomy and thrombectomy devices market is expected to grow due to an increase in the prevalence of cardiovascular disorders, such as high blood pressure, coronary artery disease, arrhythmia, congestive heart failure, cardiac arrest, stroke, peripheral artery disease, and congenital heart diseases, during the forecast period.
The global increase in the senior population, lifestyle-related changes, and genetic problems among the population base are all contributing to the atherectomy and thrombectomy devices market share, giving the market room to grow. Treatment of atherosclerosis becomes necessary to avert the advancement of additional major CVDs, and the use of atherectomy devices has become commonplace.
The adoption of advanced technologies such as laser and ultraviolet radiation, recombinant tissue technology, helicutters, and 3D image production is also likely to provide the atherectomy and thrombectomy devices market opportunities.
The research on the global atherectomy and thrombectomy devices market includes a comprehensive analysis of the market for the predicted period. The research includes several sectors, as well as an analysis of the atherectomy and thrombectomy devices market trends.
These atherectomy and thrombectomy devices market dynamics variables include the drivers, opportunities, restraints, and challenges, as well as the impact of these factors on the market. The drivers and limits are intrinsic to the atherectomy and thrombectomy devices market, while the possibilities and difficulties are extrinsic.
The atherectomy and thrombectomy devices market outlook projects revenue growth throughout the forecast period.
Which is the Leading Segment in the Atherectomy and Thrombectomy Devices Market by Type?
According to PMR analysis, based on Type, the rotational segment has the highest potential in the atherectomy and thrombectomy devices market, with a CAGR of 5.7% during the forecast period. The radial or femoral artery access can be used for rotational atherectomy. Rotational atherectomy is usually the best approach for ostial disease, since it provides more control, especially for tight and severely calcified lesions.
As the clinical benefits provided (such as the lack of barotrauma, reduced risk of neointimal hyperplasia, immediate change of bypass site, and availability of different-sized instruments to enable atherectomy in blood vessels), as well as ongoing technological advancements, are promoting rotational atherectomy and thrombectomy.
Which is the Leading Segment in the Atherectomy and Thrombectomy Devices Market by Application?
Based on application, hospitals are the leading segment, with a CAGR of 5.8% during the forecast period. As hospitals have more working capital to spend on innovative medical technologies, they will take the lead. As hospitals are typically multi-specialty hubs, they must store the necessary medical instruments to provide comprehensive care to patients.
Growing adoption of atherectomy for cardiac and peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries are all factors contributing to this segment's large share.
| Regions | CAGR (2022-2032) |
|---|---|
|
United States |
5.4% |
|
United Kingdom |
4.4% |
|
China |
5% |
|
Japan |
4.1% |
|
South Korea |
3.6% |
North America is predicted to hold the greatest market share of US$ 2.2 billion during the forecast period. Factors such as increased reimbursements for atherectomy systems, the enormous patient population with peripheral and coronary artery illnesses, medical professional adoption of atherectomy systems, and an increasing number of clinical trials are all contributing to this trend.
The US is expected to have a CAGR of 5.5% during the forecast period. Aside from the aforementioned considerations, the increased interest of atherectomy device vendors in the region helps to boost regional product demand.
Furthermore, rising government initiatives to raise awareness and the need for better health care infrastructure are driving the atherectomy and thrombectomy devices market in North America throughout the forecast period.
Due to improved health care infrastructure, more patient awareness, and increased disposable income, the Asia Pacific atherectomy and thrombectomy devices market is expected to grow at a quicker rate over the projected period. Japan is expected to have a CAGR of 4.1 during the forecast period, whereas China is anticipated to have a slightest higher CAGR of 5% by 2032.
The majority of atherectomy and thrombectomy devices market competition is built on delivering innovative and efficient services. The data shows how rivals earn from the market for atherectomy and thrombectomy devices.
Key actors prioritize major collaborations, mergers and acquisitions, as well as contemporary innovation and business methods. Atherectomy and thrombectomy devices vendors should think about establishing a portfolio-synergistic approach with top-down planning.
By Type
By Application
By Region
To know more about delivery timeline for this report Contact Sales
The atherectomy and thrombectomy devices market is projected to have a CAGR of 5.7% during the forecast period.
The US is the leading region, with an anticipated CAGR of 5.4% through 2032.
Rotational segment leads the market with the projected CAGR of 5.7% through 2032.
The atherectomy and thrombectomy devices market is predicted to grow to US$ 6 billion by 2032.
Hospital segment leads the market with the projected CAGR of 5.8% by 2032.
